Journals / Izmir Democracy University Health Sciences Journal / 2019 / Cilt: 2 Sayı: 3

RECURRENT AMELOBLASTOMA: A CASE REPORT

TEKRARLAYAN AMELOBLASTOMA: BİR OLGU SUNUMU

Zozan Erdoğmuş(Diyarbakır Ağız ve Diş Sağlığı Merkezi)0000-0002-9706-3862
Mahmut Koparal(ADIYAMAN ÜNİVERSİTESİ)0000-0003-1817-1230
Pages
177–182
Publication Date
2019-12-29
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

No recurrent was seen during the following period of three years.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Ameloblastoma is a tumor of odontogenic type, arising from the epithelium with fibrous stroma and enamel organ in different steps of evolution.
📊
Key Findings & Data:It arises in the molar-ramus region of mandible with a ratio of 80%.
💡
Conclusion & Impact:No recurrent was seen during the following period of three years.
🔬Design:Olgu Sunumu
📍Scope:Comprehensive Sample
⚙️Variables:Ameloblastoma · Marjinal Rezeksiyon · nüks

Abstract

Ameloblastoma is a tumor of odontogenic type, arising from the epithelium with fibrous stroma and enamel organ in different steps of evolution. Ameloblastoma is an odontogenic tumor that is located in the jaw region and though it is a benign entity it may be locally invasive. They are usually diagnosed between the third and fourth decades of life. Mandibula is more affected than maxilla. It arises in the molar-ramus region of mandible with a ratio of 80%. In small lesions enucleation or local resection are the appropriate treatment methods. But larger lesions need marginal resection. It has a high ratio of recurrence. In our case we report a recurrent ameloblastoma is presented. The patien was operated in a different of medicine with the diagnosis of ameloblastoma.We applied marginal resection. No recurrent was seen during the following period of three years.

Özet

Ameloblastoma çeşitli gelişim aşamalarındaki enamel organ ve fibröz stromalı epitelden gelişen odontojenik bir neoplazidir. Ameloblastoma, çene bölgesinde görülen, iyi huylu olmasına karşılık lokal yayılım gösteren bir tümördür. Genellikle hayatın üçüncü veya dördüncü dekatında daha sık teşhis edilirler. Mandibula maksilladan daha sık etkilenir. %80 oranında mandibular molar-ramus bölgesinde ortaya çıkar. Küçük lezyonlarda genellikle enükleasyon veya rezeksiyon yeterlidir. Fakat büyük lezyonlarda marjinal rezeksiyon gereklidir. Rekürrensi yüksektir. Sunulan bu olguda başka bir merkezde daha önce opere edilen ameloblastoma vakası sunulmuştur. Marjinal rezeksiyon yaptığımız vaka da üç yıllık takipte nüks görülmemiştir

🔖

Cite This Article

Erdoğmuş, Z., Koparal, M. (2019). RECURRENT AMELOBLASTOMA: A CASE REPORT. Izmir Democracy University Health Sciences Journal, Cilt: 2 Sayı: 3, 177–182. https://ajindex.com/articles/1499752

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (24)

  1. Almeida R. A. C., Andrade E. S. S., Barbalho J. C., Vajgel A., Vasconcelos B. C. E. (2016). Recurrence rate following treatment for primary multicystic ameloblastoma: systematic review and meta-analysis,” International Journal of Oral and Maxillofacial Surgery, 45(3), 359–367.
  2. Angadi P.V. (2011). Head and neck: odontogenic tumor: ameloblastoma. Atlas of Genetics and Cytogenetics in Oncology and Haematology, 15, 223–229.
  3. B. Ahlema, A., Wideda, L., Amanib Z., Nadiaa A., Amiraa and. Fatena F.(2015). Study of Ki67 and CD10 expression as predictive factors of recurrence of ameloblastoma. European Annals of Otorhinolaryngology, Head and Neck diseases, 132(5), 275–279.
  4. Becelli R., Carboni A., Cerulli G., Perugini M., Lannetti G. (2002). Mandibular ameloblastoma: analysis of surgical treatment carried out in 60 patients between 1977 and 1998. Journal of Craniofacial Surgery, 13(3), 395-400.
  5. Becelli R., Morello R., Renzi G., Matarazzo G., Dominici C.(2011). Treatment of recurrent mandibular ameloblastoma with segmental resection and revascularized fibula free flap. Journal of Craniofacial Surgery, 22, 1163–1165.
  6. Belli E, Rendine G, Mazzone N.(2009) Ameloblastoma relapse after 50 years from resection treatment. J Craniofac Surgery, 20,1146–1149.
  7. Chaine A., Pitak-Arnnop P., Dhanuthai K., Ruhin-Poncet B., Bertrand JC., Bertolus C. (2009). A treatment algorithm for managing giant mandibular ameloblastoma: 5-year experiences in a Paris University Hospital. European Journal of Surgical Oncology, 35, 999–1005.
  8. Cihangiroğlu M., Akfırat M., Yıldırım H.(2002).CT and MRI findings of ameloblastoma in two cases. Neuroradiology, 44, 434-437. Damjanov I, Linder J. (1996). Anderson's Pathology( 10th ed.). St. Louis: MosbyYear Book,1603.
  9. El-Naggar, Chan JKC, Grandis JR, Takata T, Slootweg P, editors(2017). WHO classification of Head and Neck Tumours (chapter 8). Odontogenic and maxilofacial bone tumours. 4th ed., IARC: Lyon, 205-260.
  10. Escande C., Chaine A., Menard P.(2009). A treatment algorithm for adult ameloblastomas according to the Pitié-Salpêtrière Hospital experience. Journal Craniomaxillofacial of Surgery, 37, 363–369.
  11. Fregnani ER., da Cruz Perez DE., de Almeida OP., Kowalski LP., Soares FA., de Abreu Alves F.(2010). Clinicopathological study and treatment outcomes of 121 cases of ameloblastomas. International Journal Oral Maxillofacial Surgery, 39, 145–149.
  12. Hong J., Yun PY., Chung IH. (2007). Long-term follow up on recurrence of 305 ameloblastoma cases. International Journal of Oral Maxillofacial Surgery, 36, 283–288.
  13. Jun Li T,Tang Wu Y,Feng Yu S,Yan Yu G.(2000). Unicystic ameloblastoma. American Journal of Surgical Pathology,24,1385-1392.
  14. Kim SG., Jang HS.(2001). Ameloblastoma: a clinical, radiographic, and histopathologic analysis of 71 cases. Oral Surgery Oral Med Oral Pathol Oral Radiology Endodonti, 91, 649–653.
  15. Lau S K, Tideman H,Wu PsC.(1998). Ameloblastic carcinoma of the jaws. Oral Surgery Oral Medicine, Oral Pathology, Oral Radiology and Endodontics,85,78-81.
  16. Ledesma M.C., Mosqueda T. A., Carlos B. R., León E.R., Palma Guzmán JM, Paéz-Valencia C, Meneses-García A. (2007). Ameloblastomas: a regional Latin America multicentric study. Oral Diseases,13,303–307.
  17. Pogrel MA., Montes DM. (2009). Is there a role for enucleation in the management of ameloblastoma? International Journal of Oral Maxillofacial Surgery, 38, 807–812.
  18. Ram R.(2010). Ameloblastoma relapse after 16 years of resection in symphysis of mandible sparing the bone graft. National Journal of Maxillofacial Surgery, 1(2), 190-193.
  19. Reichart PA, Philipsen HP, Sonner S.(1995). Ameloblastoma: Biological Profile of 3677 Cases. Oral Oncol Eur J Cancer;31B,86-99 Rosai J. (1996). Ackerman's Surgical Pathology (8th ed.). St. Louis: Mosby-Year Book,271-274.
  20. Sayın B., Kabaçam G., Yıldırım N., Güler Ö., Dede D. (2004). Granüler hücreli dev ameloblastoma. Ankara Üniversitesi Tıp Fakültesi Mecmuası, 4, 267-271.
  21. Sehdev MK, Huvos AG, Strong EW, Gerold FP, Willis GW.(1974). Ameloblastoma of maxilla and mandible. Cancer J.,33,324-333.
  22. Torres-Lagares D., Infante-Cossio P., Hernandez-Guisado JM., Gutiérrez-Pérez JL.(2005). Mandibular ameloblastoma. A review of the literature and presentation of six cases. Med Oral Patol Oral Cir Bucal,10,231–238.
  23. Unni KK., Inwards C.Y. (1996). Dahlin's Bone Tumors( 5th edition). Philadelphia: Lippincott-Raven,436-439.
  24. Jun Li T,Tang Wu Y,Feng Yu S,Yan Yu G.(2000). Unicystic ameloblastoma. American Journal of Surgical Pathology,24,1385-1392.